Clinical trial
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II…
NCT00160160 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00160160 |
|---|---|
| Title | Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes |
| Official title | A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2 |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypertension, Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | eprosartan/HCTZ |
| Enrollment | 440 |
| Start date | Oct 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 30, 2009 |
| Countries | Canada, Denmark, France, Germany, Italy, Norway, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: